Global submission seeks approval for sugemalimab treatment in stage 3 non-small cell lung cancer after chemoradiotherapy, supported by phase 3 GEMSTONE-301 study results. A Type 2 variation application has been submitted to the European Medicines Agency seeking approval for treatment […]
Global Submission Seeks Approval for Sugemalimab Treatment in NSCLC Read More »
Cretostimogene shows best-in-class durability of response for BCG-unresponsive NMIBC with CIS: © pikovit – stock.adobe.com. Treatment with cretostimogene monotherapy continues to demonstrate best-in-class durability of response and consistent safety and efficacy in patients with high-risk, Bacillus Calmette-Guérin (BCG)–unresponsive non-muscle invasive
Cretostimogene Has Durable Response in BCG-Unresponsive Bladder Cancer Read More »
SpaceOAR Hydrogel reduces the risk of bowel complications and need for procedures like colonoscopy in prostate cancer patients receiving radiation therapy, study shows. The utility of SpaceOAR Hydrogel, a polyethylene glycol-based hydrogel spacer placed between the prostate and rectum, led
Reducing Bowel Complications Following Radiation in Prostate Cancer Read More »
Dr. Debu Tripathy discusses how circulating tumor DNA is used to in breast cancer detection and how it can also indicate the presence of minimal residual disease. Circulating tumor DNA (ctDNA) is described by The University of Texas MD Anderson
Advancing ctDNA for Minimal Residual Disease Detection in Breast Cancer Read More »
Dr. Regina Hampton illustrates how genomic insights have improved patient outcomes in breast cancer: © stock.adobe.com Breast cancer research increasingly highlights the role of genomic testing in refining treatment strategies, particularly for African American women, who face distinct challenges in
Unraveling Disparities and Genomic Advances Across Breast Cancer Care Read More »
The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 gozetotide in PSMA-PET scans. The Food and Drug Administration (FDA) has approved Gozellix (TLX007-CDx), a next-generation prostate-specific membrane antigen (PSMA)–PET imaging
FDA Approves Gozellix for Advanced PSMA-PET Imaging in Prostate Cancer Read More »
Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies and the potential for improved outcomes. In a presentation at the recent 42nd Annual Miami Breast Cancer Conference and the Educated Patient Breast Cancer Summit, Dr.
Evolving Treatments and Advances in HER2-Positive Breast Cancer Read More »
FDA grants approval to an act of compassionate use treatment with Namodenoson for a patient with pancreatic cancer: © Tada Image – stock.adobe.com. The Food and Drug Administration (FDA) has granted approval to an act of compassionate use treatment with
FDA Grants Compassionate Use Treatment to Namodenoson in Pancreatic Cancer Read More »
Dr. Regina Hampton discusses the 40% higher breast cancer mortality rate in Black women, highlighting the FLEX study’s role in improving early detection and personalized treatment. Black women face a 40% higher mortality rate from breast cancer compared with other
Disparities in Breast Cancer Care, Genomic Insights and Early Detection Read More »
First patient dosed in phase 2b trial of Halneuron for chemotherapy-induced neuropathic pain, a first-in-class agent targeting the NaV 1.7 sodium channel. The first patient has been dosed in the phase 2b HALT-CINP (Halneuron® Treatment of Chemotherapy-Induced Neuropathic Pain) clinical
First Patient Dosed in Trial for Chemotherapy-Induced Neuropathic Pain Read More »
